3858 results for «2370»
3858 results
Leading dose solutions for your interventions
18 May 2021 – From EuroPCR 2021
Watch this session presented by Laurent Fieldman in order to understand how innovations can help you optimising dose in your procedures, to learn about latest dose reduction tools for complex interventions, and to review expert perspective on using innovative dose reduction tools.
The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli
18 May 2021 – From EuroPCR 2021
Watch this session presented by Raul Moreno and Dave Smith in order to learn about the hemodynamic performance of the ALLEGRA TAVI system, to share the experience of European centres through challenging ALLEGRA cases, and to focus on the outcome of the ALLEGRA TAVI system in small annuli...
Complex PCI with short DAPT: the trade-off between ischaemia and bleeding
18 May 2021 – From EuroPCR 2021
Watch this session presented by Benjamin Faurie, Roxana Mehran and Manel Sabate in order to understand the trade-off between ischaemic risk and bleeding risk, to hear about the results of LM-PCI with Biofreedom Ultra and short DAPT, and to learn how to use short DAPT in patients undergoing complex...
Short DAPT in high bleeding risk: ready for prime time?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...
Early real-world experience with Tendyne™ TMVR
18 May 2021 – From EuroPCR 2021
Watch this session presented by Stephan von Bardeleben in order to learn about real-world Tendyne results from TENDER EU, the largest reported commercial cohort, to hear expert feedback on the safety and effectiveness of Tendyne TMVI in real-life setting, and to discover how one heart team integrates Tendyne...
A case-based approach: finding balance between bleeding and ischemic risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by David Kandzari, Mirvat Alasnag, Emmanouil Brilakis, Chorcheung Frankie Tam and Beatriz Vaquerizo in order to debate case complexity of patient characteristics and complex lesions in HBR patients, to review patient centered clinical judgment and individualised treatment plans, and to analyse current Onyx ONE...
The PASCAL platform: successfully and confidently treating MR
18 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas van Mieghem, Fabien Praz and Peter Lüdike in order to learn about the PASCAL platform and its differentiated features, to discuss how to identify patients for the treatment with the PASCAL platform, and to review clinical data and discuss patient outcomes...
RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Atul Pathak in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...
SELUTION DeNovo study: powered to change medical practice
18 May 2021 – From EuroPCR 2021
Watch this session presented by Christian Spaulding in order to gain insight into how the SELUTION DeNovo study could change medical practice, to understand the strategy and what differentiates the SELUTION DeNovo study, and to learn about the study design and key milestones.
Percutaneous tricuspid valve repair: how to perform it - Session with LIVE demonstration
19 May 2021 – From EuroPCR 2021
Watch this session if you want to learn how to select patients, to understand how to perform a percutaneous tricuspid repair and to gain tips and tricks.
This session was originally presented during EuroPCR 2021.
What is a healing-targeted drug-eluting stent and how is it different to a normal stent?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...
The latest on the prevail drug-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Azeem Latib and Antonio Colombo in order to reflect on the latest information on Prevail DCB and study, to explore DCB technology and hear the expert-recommended indications, and to gain insights through an interesting PI case using Prevail DCB.
Uncrossable lesions
18 May 2021 – From EuroPCR 2021
Thanks to this session, get to know how to treat an uncrossable lesion, and especially in patients with inferior STEMI.
Surgery or PCI?
18 May 2021 – From EuroPCR 2021
In this session, discover a case when the surgeon ́s ambitions are higher than his courage.
Which way to choose?
18 May 2021 – From EuroPCR 2021
Watch this video to check whether you would have opted for the same vessel and the same strategy when facing this NSTEMI case.
Emergency cases in the cathlab: there is not just ACS and PCI
18 May 2021 – From EuroPCR 2021
Look at this video presenting a patient with massive bilateral central pulmonary embolism: how would you treat?
Challenging TAVI cases
18 May 2021 – From EuroPCR 2021
In this session, look at TAVR complications, study how to find a way to deliver an aortic valve prosthesis, and think about how to treat a failing tissue AVR in a fit 60 year-old doctor.
Dealing with shock
18 May 2021 – From EuroPCR 2021
Find out more about left main shock syndrome, always an unpredictable situation, and study the case of a STEMI patient with cardiogenic shock.
Challenging heart failure and mitral regurgitation cases
18 May 2021 – From EuroPCR 2021
In this session, analyze the cases of a young patient with multivessel coronary disease and severe heart failure, and a patient with heart failure, prior rigid mitral ring replacement, and severe mitral regurgitation.
Mitral valve challenges
18 May 2021 – From EuroPCR 2021
Watch this session to find out more about flail bioprosthetic mitral valve treatment, acute prosthetic mitral valve regurgitation, severe structural and non-structural mitral bioprosthesis degeneration, and severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement
